Back to search results

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Abroad (travel likely)Recruiting

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

    Study coordinator · 303-724-8249
    Contact: Principal Investigator (Anna Shah)

  • IQVIA US Office, Durham, North Carolina, United States

    Study coordinator · 833-569-2635
    Contact: Principal Investigator (Sydney Willis)

  • Austin Hospital, Heidelberg, Australia

  • Katholisches Klinikum Bochum, Bochum, North Rhine-Westphalia, Germany

    Study coordinator · +492345092420
    Contact: Principal Investigator (Kerstin Hellwig)

  • St Vincent's University Hospital, Dublin, Ireland

    Study coordinator · +35312773592
    Contact: Principal Investigator (Christopher McGuigan)

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

    Study coordinator · +34913368397
    Contact: Principal Investigator (Lucienne Costa-Frossard)

  • Inselspital, Bern, Switzerland

    Study coordinator · 41316641250
    Contact: Principal Investigator (Helly Hammer)
Study leads

  • Medical Director

    Study Director

    Biogen

View source on ClinicalTrials.gov(opens in a new tab)